Accuracy and safety of percutaneous CT-guided pancreatic biopsies
La radiologia medica · 19.09.2025 · 130 (12) · 1903-1908
DOI: 10.1007/s11547-025-02087-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift La radiologia medica, online erschienen am 19.09.2025. Verfasst von Thomas J Vogl und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Radiology and Nuclear Medicine, University Hospital Frankfurt, Johann Wolfgang Goethe University, Frankfurt, Germany. Hauptthemen laut MEDLINE: Tomography, X-Ray Computed, Image-Guided Biopsy, Pancreatic Neoplasms, Radiography, Interventional. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johann Wolfgang Goethe-Universität, Frankfurt am Main.
Abstract (Originalsprache)
Purpose
To assess the accuracy and safety of CT-guided percutaneous core-needle biopsies of pancreatic lesions suspected to be malignant based on MRI or CT scans. Materials and methods This retrospective study analyzed CT-guided percutaneous biopsies of suspicious pancreatic lesions performed at our university hospital. Biopsy was performed using a 17G coaxial needle and an 18G core biopsy needle. Data on patient characteristics, lesions, procedures, and histologic results were recorded.
Results
A total of 90 patients (58.9% males, mean age 65 ± 12.2 years) underwent CT-guided percutaneous biopsies. The lesions had a mean size of 36.8 ± 12.2 mm and were predominantly located in the pancreatic head 61.1% (55/90). Technical success was achieved in all biopsies 100% (90/90). Most procedures 96.7% (87/90) were performed using direct access routes, while 3.3% (3/90) required indirect transhepatic or transgastric approaches. Among the biopsies, 65.6% (59/90) confirmed malignancy, with adenocarcinoma as the most common malignant subtype representing 55.6% (50/90) of all cases. The rate of non-malignant findings was 26.7% (24/90) including chronic pancreatitis at a rate of 5.6% (5/90) as well as pancreatic pseudocysts and pancreatic cystadenoma each at a rate of 2.2% (2/90), among others. A total of seven cases were identified as false negatives confirmed, but malignancy was later confirmed after re-biopsy or surgery. The initial diagnostic accuracy was 92.2% (83/90). The rate of major complications was 1.1% (1/90), and a total of two minor complications at a rate of 2.2% were observed.
Conclusion
This study shows that CT-guided pancreatic biopsy is a safe procedure with high diagnostic accuracy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic for Radiology and Nuclear Medicine, University Hospital Frankfurt, Johann Wolfgang Goethe University, Frankfurt, Germany.
- Clinic for Radiology and Nuclear Medicine, University Hospital Frankfurt, Johann Wolfgang Goethe University, Frankfurt, Germany. adwan.hamza97@gmail.com.
- Department of Neuroradiology, University Hospital Frankfurt, Johann Wolfgang Goethe University, Frankfurt, Germany.
Förderung
- Johann Wolfgang Goethe-Universität, Frankfurt am Main
Zitieren
APA
Vogl, T. J., Adwan, H., Mann, L., & Al Haj Ibrahem, I. (2025). Accuracy and safety of percutaneous CT-guided pancreatic biopsies. La radiologia medica, 130(12), 1903-1908. https://doi.org/10.1007/s11547-025-02087-8
Vancouver
Vogl TJ, Adwan H, Mann L, Al Haj Ibrahem I. Accuracy and safety of percutaneous CT-guided pancreatic biopsies. La radiologia medica. 2025;130(12):1903-1908. doi:10.1007/s11547-025-02087-8
BibTeX
@article{Vogl2025,
author = {Vogl, Thomas J and Adwan, Hamzah and Mann, Leonhard and Al Haj Ibrahem, Ibrahem},
title = {Accuracy and safety of percutaneous CT-guided pancreatic biopsies},
journal = {La radiologia medica},
year = {2025},
volume = {130},
number = {12},
pages = {1903--1908},
doi = {10.1007/s11547-025-02087-8}
}
EUVIMED